Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | 3-dinitrobenzene results in decreased expression of CSTF2T mRNA | CTD | PMID:21983209 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF2T mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CSTF2T mRNA | CTD | PMID:33387578 | 3',5'-cyclic UMP | affects binding | ISO | CSTF2T (Homo sapiens) | 6480464 | CSTF2T protein binds to cyclic 3' and 5'-uridine monophosphate | CTD | PMID:30528433 | aflatoxin B1 | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of CSTF2T mRNA | CTD | PMID:33354967 | all-trans-retinoic acid | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CSTF2T mRNA | CTD | PMID:21934132 | bisphenol A | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CSTF2T mRNA | CTD | PMID:25181051 and PMID:33296240 | C60 fullerene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of CSTF2T mRNA | CTD | PMID:19167457 | cadmium atom | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Cadmium results in decreased expression of CSTF2T mRNA | CTD | PMID:24376830 | cadmium dichloride | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CSTF2T mRNA | CTD | PMID:33453195 | copper(II) sulfate | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CSTF2T mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CSTF2T mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CSTF2T mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CSTF2T protein | CTD | PMID:23301498 | fipronil | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | fipronil results in decreased expression of CSTF2T mRNA | CTD | PMID:23962444 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF2T mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | ISO | CSTF2T (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CSTF2T protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CSTF2T mRNA | CTD | PMID:22061828 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | iron atom | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Iron deficiency results in decreased expression of CSTF2T mRNA | CTD | PMID:20368581 | iron(0) | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Iron deficiency results in decreased expression of CSTF2T mRNA | CTD | PMID:20368581 | ivermectin | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CSTF2T protein | CTD | PMID:32959892 | methapyrilene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of CSTF2T mRNA | CTD | PMID:30467583 | methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of CSTF2T mRNA | CTD | PMID:18502557 | methylmercury chloride | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CSTF2T mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CSTF2T mRNA | CTD | PMID:35430440 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CSTF2T mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CSTF2T mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSTF2T mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CSTF2T mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of CSTF2T mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CSTF2T mRNA | CTD | PMID:18445702 | SB 431542 | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CSTF2T mRNA | CTD | PMID:23806026 | sunitinib | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CSTF2T mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of CSTF2T mRNA | CTD | PMID:31758290 | thioacetamide | affects methylation | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Thioacetamide affects the methylation of CSTF2T promoter | CTD | PMID:25151969 | thioacetamide | affects expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Thioacetamide affects the expression of CSTF2T mRNA | CTD | PMID:25151969 | topotecan | affects response to substance | ISO | CSTF2T (Homo sapiens) | 6480464 | CSTF2T protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | trichloroethene | decreases expression | ISO | Cstf2t (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CSTF2T mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CSTF2T mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CSTF2T mRNA | CTD | PMID:28973697 | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of CSTF2T mRNA | CTD | PMID:35537566 | urethane | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Urethane results in decreased expression of CSTF2T mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CSTF2T mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CSTF2T mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | CSTF2T (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CSTF2T mRNA | CTD | PMID:27188386 | vitamin D | affects expression | ISO | CSTF2T (Homo sapiens) | 6480464 | Vitamin D affects the expression of CSTF2T mRNA | CTD | PMID:20368581 | |